ArticleBlood2017

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Harriet S Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.